Literature DB >> 16105374

The challenge of recruiting people with schizophrenia to a health promotion trial.

Margaret Abbott1, Antony Arthur, Liz Walker, Gillian Doody.   

Abstract

People with schizophrenia have an increased risk of coronary heart disease. This pilot study tested the feasibility of carrying out a randomised controlled trial to compare coronary heart disease prevention for this population through an enhanced occupational therapy support intervention versus a practice-based intervention. Difficulty in deciding whether to take part meant that 123 visits were made to 25 people with 12 ultimately providing informed consent. Participants' discussion at a subsequent focus group (n = 3) suggested a poor understanding of the study process. Distrust of randomisation suggests that randomised controlled trials may not be the best way to evaluate community-based interventions for people with schizophrenia.

Entities:  

Mesh:

Year:  2005        PMID: 16105374      PMCID: PMC1463241     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  4 in total

1.  Causes of the excess mortality of schizophrenia.

Authors:  S Brown; H Inskip; B Barraclough
Journal:  Br J Psychiatry       Date:  2000-09       Impact factor: 9.319

2.  Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study.

Authors:  R G McCreadie
Journal:  Br J Psychiatry       Date:  2003-12       Impact factor: 9.319

3.  Participation in screening for cardiovascular risk by people with schizophrenia or similar mental illnesses: cross sectional study in general practice.

Authors:  D P J Osborn; M B King; I Nazareth
Journal:  BMJ       Date:  2003-05-24

Review 4.  Hyperglycemia and antipsychotic medications.

Authors:  D W Haupt; J W Newcomer
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

  4 in total
  5 in total

1.  The challenge of recruiting people with schizophrenia to trials.

Authors:  Sarah Cook; Eleni Chambers; Julie Coleman; Melanie Hart
Journal:  Br J Gen Pract       Date:  2005-12       Impact factor: 5.386

2.  Adapting Peer Researcher Facilitated Strategies to Recruit People Receiving Mental Health Services to a Tobacco Treatment Trial.

Authors:  Amanda L Baker; Kristen McCarter; Lisa Brophy; David Castle; Peter J Kelly; Nadine Cocks; Melissa L McKinlay; Catherine Brasier; Ron Borland; Billie Bonevski; Catherine Segan; Donita E Baird; Alyna Turner; Jill M Williams; Erin Forbes; Laura Hayes; John Attia; David Lambkin; Daniel Barker; Rohan Sweeney
Journal:  Front Psychiatry       Date:  2022-05-26       Impact factor: 5.435

3.  Therapeutic effects of maximal strength training on walking efficiency in patients with schizophrenia - a pilot study.

Authors:  Jørn Heggelund; Gunnar Morken; Jan Helgerud; Geir E Nilsberg; Jan Hoff
Journal:  BMC Res Notes       Date:  2012-07-03

4.  Effects of high aerobic intensity training in patients with schizophrenia: a controlled trial.

Authors:  Jørn Heggelund; Geir E Nilsberg; Jan Hoff; Gunnar Morken; Jan Helgerud
Journal:  Nord J Psychiatry       Date:  2011-02-18       Impact factor: 2.202

5.  Feasibility, Acceptability, and Preliminary Impacts of Web-Based Patient Education on Patients With Schizophrenia Spectrum Disorder: Quasi-Experimental Cluster Study.

Authors:  Anna Laine; Maritta Välimäki; Virve Pekurinen; Eliisa Löyttyniemi; Mauri Marttunen; Minna Anttila
Journal:  J Med Internet Res       Date:  2019-10-17       Impact factor: 5.428

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.